Results
21
Companies which are more than 50% undervalued based on analyst price target.
21 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GRF | €8.53 | -3.9% | -15.9% | €5.3b | €16.32 | PE35.9x | E30.3% | n/a | Pharmaceuticals & Biotech | ||
SLR | €7.42 | -5.3% | -45.8% | €927.1m | €12.64 | PE11.9x | E11.0% | n/a | Utilities | ||
COXG New | €9.48 | 0.2% | n/a | €736.8m | €14.33 | PE11.1x | E17.9% | n/a | Utilities | ||
ADX | €1.46 | -2.3% | 10.6% | €656.1m | €2.38 | PE12.7x | E8.8% | 0% | Utilities | ||
DOM | €3.08 | -2.2% | -13.6% | €461.9m | €6.12 | PE9.7x | E12.4% | 3.2% | Software | ||
GSJ | €5.50 | 2.6% | 33.5% | €357.6m | €9.62 | PE11.4x | E-6.2% | 2.7% | Capital Goods | ||
PRS | €0.33 | -0.3% | 13.4% | €356.5m | €0.50 | PS0.4x | E125.9% | n/a | Media | ||
ATRY | €3.55 | -2.5% | 1.7% | €269.6m | €6.40 | PS1.3x | E91.4% | n/a | Healthcare | ||
PRM | €9.68 | 0.4% | -6.5% | €164.7m | €16.75 | PE14.4x | n/a | 4.6% | Healthcare | ||
GGR New | €5.48 | -4.2% | 6.2% | €158.7m | €8.40 | PE45.4x | E50.4% | n/a | Capital Goods | ||
SOL | €1.60 | 0% | -52.6% | €145.3m | €3.00 | PS0.4x | E70.8% | n/a | Capital Goods | ||
GAM | €1.27 | -0.8% | -3.8% | €119.7m | €2.10 | PE13.2x | E20.3% | n/a | Capital Goods | ||
ORY | €1.44 | -2.6% | -25.1% | €93.1m | €6.17 | PS6.1x | E52.2% | n/a | Pharmaceuticals & Biotech | ||
GIGA | €6.40 | 1.6% | -7.8% | €74.2m | €10.10 | PS1x | n/a | n/a | Software | ||
CLR | €4.60 | -0.6% | 25.3% | €67.2m | €12.30 | PE84.5x | E73.5% | n/a | Capital Goods | ||
AGIL | €2.74 | -4.9% | -15.7% | €63.1m | €6.50 | PS0.6x | E-16.9% | n/a | Software | ||
NBI | €3.82 | -4.5% | -17.0% | €45.8m | €6.15 | PE21.7x | n/a | 0% | Capital Goods | ||
TR1 | €3.00 | 0% | 33.3% | €29.3m | €5.00 | PE17.2x | n/a | 2.6% | Software | ||
MIO | €2.70 | -0.7% | -37.8% | €17.6m | €6.00 | PS0.3x | n/a | n/a | Media | ||
KOM | €1.04 | 0% | 34.2% | €12.4m | €2.00 | PS0.3x | E90.3% | n/a | Materials | ||
COM New | €0.64 | -0.8% | -20.8% | €11.6m | €1.00 | PS1x | n/a | 0% | Commercial Services |